Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Acute Lymphocytic Leukemia Refractory
Düsseldorf, North Rhine-Westphalia
Acute Lymphocytic Leukemia Refractory Clinical Trials in Düsseldorf, North Rhine-Westphalia
1 recruiting
Düsseldorf, North Rhine-Westphalia, Germany
Showing
1–1
of
1
trials
Recruiting
Phase 1
Phase 2
Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia
ALL, Childhood B-Cell
Acute Lymphoid Leukemia Relapse
Acute Lymphocytic Leukemia Refractory
University Hospital Tuebingen
20 enrolled
11 locations
NCT05366218
Feedback